TLR2 and neoplasm: The HMGB1 released from the necrotic tumor executes alarmin functions, activating tumor growth signaling via binding to a variety of receptors including TLR2/4, RAGE, and C-X-C motif chemokine receptor 4 (CXCR-4) [43, 44].